Comments on effect of food on early drug exposure from extended-release stimulants:: Results from the CONCERTA®, Adderall XR® food evaluation study

被引:2
|
作者
González, MA
Polli, JE
Morgan, JA
机构
[1] GloboMax Amer LLC, Weston, FL 33326 USA
[2] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA
[3] Univ Maryland, Med Ctr, Dept Pharm Practice & Sci, Baltimore, MD 21201 USA
关键词
D O I
10.1185/030079902125001218
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:VII / X
页数:4
相关论文
共 50 条
  • [21] TRANxITION 144-week results: switching virologically stable HIV patients from immediate-release nevirapine (NVP IR) to extended-release NVP (XR)
    Arasteh, K.
    Drulak, M.
    Guo, J.
    Livrozet, J.
    Orkin, C.
    Quinson, A.
    Ward, D.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2012, 15 : 160 - 160
  • [22] US Food and Drug Administration's Risk Evaluation and Mitigation Strategy for Extended-Release and Long-Acting Opioids Pros and Cons, and a European Perspective
    Mercadante, Sebastiano
    Craig, David
    Giarratano, Antonello
    DRUGS, 2012, 72 (18) : 2327 - 2332
  • [23] Evaluation of the Relative Abuse of an OROS Extended-release Hydromorphone HCI Product: Results From 3 Postmarket Surveillance Studies
    Butler, Stephen F.
    McNaughton, Emily C.
    Black, Ryan A.
    Cassidy, Theresa A.
    CLINICAL JOURNAL OF PAIN, 2018, 34 (07): : 618 - 628
  • [24] Bioequivalence and Food Effect of Dapagliflozin/Saxagliptin/Metformin Extended-release Fixed-combination Drug Products Compared With Coadministration of the Individual Components in Healthy Subjects
    Tang, Weifeng
    Engman, Helena
    Zhu, Yali
    Dayton, Brian
    Boulton, David W.
    CLINICAL THERAPEUTICS, 2019, 41 (08) : 1545 - 1563
  • [25] A Randomized, Crossover Study on the Effect of Food on the Pharmacokinetic Characteristics of Morphine ARER (MorphaBond™ ER), an Abuse-Deterrent Formulation of Extended-Release Morphine
    Kinzler, Eric R.
    Pantaleon, Carmela
    Iverson, Matthew
    Aigner, Stefan
    ADVANCES IN THERAPY, 2019, 36 (09) : 2394 - 2401
  • [26] A Randomized, Crossover Study on the Effect of Food on the Pharmacokinetic Characteristics of Morphine ARER (MorphaBond™ ER), an Abuse-Deterrent Formulation of Extended-Release Morphine
    Eric R. Kinzler
    Carmela Pantaleon
    Matthew Iverson
    Stefan Aigner
    Advances in Therapy, 2019, 36 : 2394 - 2401
  • [27] EVALUATION OF DIFFERENT METRICS AS INDIRECT MEASURES OF RATE OF DRUG ABSORPTION FROM EXTENDED-RELEASE DOSAGE FORMS AT STEADY-STATE
    REPPAS, C
    LACEY, LF
    KEENE, ON
    MACHERAS, P
    BYE, A
    PHARMACEUTICAL RESEARCH, 1995, 12 (01) : 103 - 107
  • [28] Effect on Verbal (Phonemic) Fluency and Patient Satisfaction in Chronic Migraine Patients Converted from Immediate-Release Topiramate (TPM-IR) to Extended-Release Topiramate (Trokendi XR®)
    Rothrock, John
    Michael, Amanda
    Andress-Rothrock, Diane
    NEUROLOGY, 2017, 88
  • [29] Effect on Verbal (Phonemic) Fluency and Patient Satisfaction in Chronic Migraine Patients Converted from Immediate-Release Topiramate (TPM-IR) to Extended-Release Topiramate (Trokendi XR®)
    Rothrock, J. F.
    Michael, A.
    Andress-Rothrock, D.
    HEADACHE, 2017, 57 : 196 - 196
  • [30] Extended-release metformin improves cognitive impairment in frail older women with hypertension and diabetes: preliminary results from the LEOPARDESS Study
    Pasquale Mone
    Giuseppe Martinelli
    Angela Lucariello
    Anna Luisa Leo
    Anna Marro
    Stefano De Gennaro
    Stefania Marzocco
    Divina Moriello
    Salvatore Frullone
    Luigi Cobellis
    Gaetano Santulli
    Cardiovascular Diabetology, 22